Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPharos Energy Regulatory News (PHAR)

Share Price Information for Pharos Energy (PHAR)

Share Price is delayed by 15 minutes
Get Live Data
25.10    -0.30 (-1.18%)
Bid:
24.70
Ask:
25.20
Spread: 0.50 (2.024%)
Market Cap: £103.94m
PHAR Live PriceLast checked at - London Stock Exchange

Intraday Pharos Energy Share Chart

Form 8.3 - Pharos Energy plc

Today 15:15

Aberforth Partners LLP - Form 8.3 - Pharos Energy plc

Aberforth Partners LLP - Form 8.3 - Pharos Energy plc

PR Newswire

LONDON, United Kingdom, June 24

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON

WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1.   KEY INFORMATION

(a)   Full name of discloser:

Aberforth Partners LLP, on behalf of discretionary clients.

(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):

  The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:

  Use a separate form for each offeror/offeree

Pharos Energy plc

 

(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e)   Date position held/dealing undertaken:

  For an opening position disclosure, state the latest practicable date prior to the disclosure

23/06/2026

 

(f)   In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

  If it is a cash offer or possible cash offer, state “N/A”

N/A

 

2.   POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a)   Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

 

Ordinary Shares

Interests

Short positions

Number

%

Number

%

(1)   Relevant securities owned and/or controlled:

59,357,027

14.258%

 

0

 

0.0

(2)   Cash-settled derivatives:

 

 

(3)   Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

  TOTAL:

59,357,027

14.258%

 

0

 

0.0

 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b)   Rights to subscribe for new securities (including directors’ and other employee options)

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

3.   DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

 

(a)   Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

N/A- Opening Disclosure

(b)   Cash-settled derivative transactions

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

N/A

 

 

 

 

 

(c)   Stock-settled derivative transactions (including options)

(i)   Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

 

 

 

 

 

 

 

(ii)   Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/A

(d)   Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

4.   OTHER INFORMATION

(a)   Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b)   Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i)   the voting rights of any relevant securities under any option; or

(ii)   the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c)   Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

 

24 June 2026

Contact name:

Michael Campbell, for Aberforth Partners LLP

Telephone number:

0131 220 0733

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

 



Date   Source Headline
4th Aug 20227:00 amRNSTransaction in Own Shares
3rd Aug 20227:00 amRNSTransaction in Own Shares
29th Jul 20225:22 pmRNSTotal Voting Rights
29th Jul 20227:00 amRNSTransaction in Own Shares
28th Jul 20227:30 amRNSDirector/PDMR Shareholding
28th Jul 20227:00 amRNSTransaction in Own Shares
27th Jul 20227:00 amRNSTransaction in Own Shares
26th Jul 20227:00 amRNSTransaction in Own Shares
25th Jul 202212:36 pmRNSStandard form for notification of major holdings
25th Jul 20227:00 amRNSTransaction in Own Shares
21st Jul 20227:00 amRNSTransaction in Own Shares
20th Jul 20227:05 amRNSInitiation of Share Buyback Programme
20th Jul 20227:00 amRNSTrading and Operations Update July 2022
8th Jul 20224:41 pmRNSSecond Price Monitoring Extn
8th Jul 20224:35 pmRNSPrice Monitoring Extension
4th Jul 20224:23 pmRNSEBT Share Purchase
28th Jun 20227:30 amRNSDIRECTORS/PDMR SHAREHOLDINGS
9th Jun 202211:47 amRNSExternal Directorship
30th May 20227:30 amRNSDirector/PDMR Shareholding
19th May 20224:36 pmRNSPrice Monitoring Extension
19th May 202210:20 amRNSResults of Annual General Meeting
19th May 20227:00 amRNS2022 AGM Trading and Operations Update
29th Apr 20224:35 pmRNSTotal Voting Rights
28th Apr 20227:30 amRNSDirector/PDMR Shareholding
22nd Apr 20223:59 pmRNSAnnual Report & Accounts and Notice of AGM
28th Mar 20227:30 amRNSDirector/PDMR Shareholding
24th Mar 20227:00 amRNSCompletion of Farm-Out Transaction
22nd Mar 20227:00 amRNSInvestor Presentation
21st Mar 20224:35 pmRNSBlock Listing Six Monthly Return
16th Mar 20227:00 amRNS2021 Preliminary Results
2nd Mar 20229:18 amRNSHolding(s) in Company
16th Feb 20227:00 amRNSNotice of Preliminary Results 2021
20th Jan 20227:00 amRNSEl Fayum Concession Signature
14th Jan 20227:00 amRNSIncreases in Director Shareholdings
13th Jan 20227:00 amRNSDirectorate changes
13th Jan 20227:00 amRNSTrading and Operations Update January 2022
29th Dec 20217:00 amRNSEl Fayum Concession Parliamentary Approval
14th Dec 202111:43 amRNSResult of General Meeting
25th Nov 20211:43 pmRNSPublication of Circular and Notice of GM
22nd Nov 20217:00 amRNSRecommencement of El Fayum Development Drilling
18th Nov 20217:00 amRNSVietnam Operational Update
11th Nov 20217:00 amRNSTGT Infill Development Drilling Programme
1st Nov 20217:00 amRNSCabinet approval of the El Fayum Amendment
29th Oct 20214:35 pmRNSTotal Voting Rights
7th Oct 20217:30 amRNSDirector/PDMR Shareholding
30th Sep 20214:35 pmRNSTotal Voting Rights
30th Sep 202110:35 amRNSExternal Directorship
16th Sep 20214:35 pmRNSBlock Listing Application
15th Sep 20217:02 amRNSInterim results for the Half-year to 30 June 2021
15th Sep 20217:00 amRNSFarm-Out of Pharos Energy's Egyptian Assets

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.